Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

 

Raised: $194,619.00
Goal: $500,000.00

 

Donate Now

 

PDF Grant Programs

Are you interested in furthering Parkinson's science? View PDF's open grant programs.

Learn More

Featured Research

What can we learn by studying genetics and Parkinson's? PDF-funded researchers Drs. Mata and Zabetian share their progress six years after launching the first large-scale survey of PD genetics in Latin America.

Learn More


Treatments/Pipeline

PDF's targeted PubMed search provides you with access to journal articles from the last 90 days that may be pertinent to Parkinson's disease research. 

Not what you're looking for? Do you need informational publications about Parkinson's targeted for people living with Parkinson's, caregivers and family members?  Please browse PDF's educational materials and programs - which are all available electronically or in print.  Order for yourself, a loved one or in bulk for your patients or support group.

Rasagiline, a Suicide Inhibitor of Monoamine Oxidases, Binds Reversibly to ?-Synuclein.
Joe Kakish, Omid Tavassoly, Jeremy S Lee
ACS Chem Neurosci 2014 Dec;
PMID: 25514361 [PubMed - as supplied by publisher]


Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease.
Anne Michel, Patrick Downey, Jean-Marie Nicolas, Dieter Scheller
PLoS One 2014 ; 9(12):e114086
PMID: 25513815 [PubMed - as supplied by publisher]


Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
Cheng-Long Xie, Wen-Wen Wang, Su-Fang Zhang, Ming-Lu Yuan, Jun-Yi Che, Jing Gan, Lu Song, Wei-En Yuan, Zhen-Guo Liu
Sci Rep 2014 ; 4:7506
PMID: 25511986 [PubMed - as supplied by publisher]


Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
Javier Castro-Hernández, Domingo Afonso-Oramas, Ignacio Cruz-Muros, Josmar Salas-Hernández, Pedro Barroso-Chinea, Rosario Moratalla, Mark J Millan, Tomás González-Hernández
Neurobiol Dis 2014 Dec;
PMID: 25511804 [PubMed - as supplied by publisher]


Stiff-person syndrome: insights into a complex autoimmune disorder.
José Fidel Baizabal-Carvallo, Joseph Jankovic
J Neurol Neurosurg Psychiatry 2014 Dec;
PMID: 25511790 [PubMed - as supplied by publisher]


Anterior cingulate dopamine turnover and behavior change in Parkinson's disease.
Catherine L Gallagher, Brian Bell, Matthew Palotti, Jen Oh, Bradley T Christian, Ozioma Okonkwo, Jitka Sojkova, Laura Buyan-Dent, Robert J Nickles, Sandra J Harding, Charles K Stone, Sterling C Johnson, James E Holden
Brain Imaging Behav 2014 Dec;
PMID: 25511521 [PubMed - as supplied by publisher]


Molecular mechanisms of placebo responses in humans.
M Pecińa, J-K Zubieta
Mol Psychiatry 2014 Dec;
PMID: 25510510 [PubMed - as supplied by publisher]


Recurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors.
Lorena R S Almeida, Guilherme T Valença, Nádja N Negreiros, Elen B Pinto, Jamary Oliveira-Filho
Parkinsons Dis 2014 ; 2014:432924
PMID: 25506466 [PubMed - as supplied by publisher]


Sleep disturbances in drug naďve Parkinson's disease (PD) patients and effect of levodopa on sleep.
Teresa Ferreira, Sudesh Prabhakar, Parampreet S Kharbanda
Ann Indian Acad Neurol 2014 Oct; 17(4):416-9
PMID: 25506163 [PubMed - as supplied by publisher]


Pathophysiology and treatment of alien hand syndrome.
Harini Sarva, Andres Deik, William Lawrence Severt
Tremor Other Hyperkinet Mov (N Y) 2014 ; 4:241
PMID: 25506043 [PubMed - as supplied by publisher]


Parkinson's disease: low-dose haloperidol increases dopamine receptor sensitivity and clinical response.
Craig J Hudson, Philip Seeman, Mary V Seeman
Parkinsons Dis 2014 ; 2014:684973
PMID: 25506040 [PubMed - as supplied by publisher]


Coordinated reset stimulation in a large-scale model of the STN-GPe circuit.
Martin Ebert, Christian Hauptmann, Peter A Tass
Front Comput Neurosci 2014 ; 8:154
PMID: 25505882 [PubMed - as supplied by publisher]


Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease.
Hiroshi Kataoka, Satoshi Ueno
Medicine (Baltimore) 2014 Dec; 93(27):e251
PMID: 25501095 [PubMed - as supplied by publisher]


Validity and Efficacy of Screening Algorithms for Assessing Deep Brain Stimulation Candidacy in Parkinson Disease.
Robert R Coleman, Vikas Kotagal, Parag G Patil, Kelvin L Chou
Mov Disord Clin Pract (Hoboken) 2014 Dec; 1(4):342-347
PMID: 25505791 [PubMed - as supplied by publisher]


Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates.
Arun Singh, Li Liang, Yoshiki Kaneoke, Xuebing Cao, Stella M Papa
J Neurophysiol 2014 Dec; :jn.00910.2014
PMID: 25505120 [PubMed - as supplied by publisher]


Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson's disease.
Adolfo Ramirez-Zamora, Max Kahn, Joannalee Campbell, Priscilla DeLaCruz, Julie G Pilitsis
J Neurol 2014 Dec;
PMID: 25504447 [PubMed - as supplied by publisher]


Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.
Bok-Nam Park, Jang-Hee Kim, Kwanjae Lee, So Hyun Park, Young-Sil An
Eur Radiol 2014 Dec;
PMID: 25504429 [PubMed - as supplied by publisher]


Medication Adherence in Patients with Parkinson's Disease.
Naveed Malek, Donald G Grosset
CNS Drugs 2014 Dec;
PMID: 25503824 [PubMed - as supplied by publisher]


5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia.
Darakhshan J Haleem
Behav Pharmacol 2014 Dec;
PMID: 25503261 [PubMed - as supplied by publisher]


Levodopa: Effect on cell death and the natural history of Parkinson's disease.
C Warren Olanow
Mov Disord 2014 Dec;
PMID: 25502620 [PubMed - as supplied by publisher]


Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
Orit Bar-Am, Tamar Amit, Lana Kupershmidt, Yuval Aluf, Danit Mechlovich, Hoda Kabha, Lena Danovitch, Vincent R Zurawski, Moussa B H Youdim, Orly Weinreb
Neurobiol Aging 2014 Oct;
PMID: 25499799 [PubMed - as supplied by publisher]


The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.
Shin-Ichi Uchida, Kazuhiro Soshiroda, Eri Okita, Mika Kawai-Uchida, Akihisa Mori, Peter Jenner, Tomoyuki Kanda
Eur J Pharmacol 2014 Dec;
PMID: 25499739 [PubMed - as supplied by publisher]


Dopamine D3 receptor agonists as pharmacological tools.
S Kassel, J S Schwed, H Stark
Eur Neuropsychopharmacol 2014 Nov;
PMID: 25498414 [PubMed - as supplied by publisher]


Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Omidreza Jafarieh, Shadab Md, Mushir Ali, Sanjula Baboota, J K Sahni, Bhavna Kumari, Aseem Bhatnagar, Javed Ali
Drug Dev Ind Pharm 2014 Dec; :1-8
PMID: 25496439 [PubMed - as supplied by publisher]


Melatonin redox activity. It's potential clinical application in neurodegenerative disorders.
El?bieta Miller, Agnieszka Morel, Luciano Saso, Joanna Saluk
Curr Top Med Chem 2014 Dec;
PMID: 25496271 [PubMed - as supplied by publisher]


Long-term, Open-label, Safety Study of Once-daily Ropinirole Extended/Prolonged Release in Early and Advanced Parkinson's Disease.
Clare W Makumi, Afsaneh Asgharian, Jeffrey Ellis, Soraya Shaikh, Teri Jimenez, Susan VanMeter
Int J Neurosci 2014 Dec; :1-30
PMID: 25495896 [PubMed - as supplied by publisher]


Activation of ?7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: Implications for Parkinson's disease.
Yuan Liu, Xiaoning Zeng, Yujian Hui, Chenlei Zhu, Jie Wu, Devin H Taylor, Juan Ji, Weimin Fan, Zuhu Huang, Jun Hu
Neuropharmacology 2014 Dec;
PMID: 25486621 [PubMed - as supplied by publisher]


Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.
A A Martinez, M G Morgese, A Pisanu, T Macheda, M A Paquette, A Seillier, T Cassano, A R Carta, A Giuffrida
Neurobiol Dis 2014 Dec;
PMID: 25486547 [PubMed - as supplied by publisher]


Environmental enrichment: Evidence for an unexpected therapeutic influence.
Robert J Kotloski, Thomas P Sutula
Exp Neurol 2014 Dec;
PMID: 25483395 [PubMed - as supplied by publisher]


Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.
Daniel O Claassen, Wery P M van den Wildenberg, Madaline B Harrison, Nelleke C van Wouwe, Kristen Kanoff, Joseph S Neimat, Scott A Wylie
Pharmacol Biochem Behav 2014 Nov; 129C:19-25
PMID: 25459105 [PubMed - as supplied by publisher]


Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles.
D M Yurek, U Hasselrot, W A Cass, O Sesenoglu-Laird, L Padegimas, M J Cooper
Neuroscience 2015 Jan; 284C:500-512
PMID: 25453772 [PubMed - as supplied by publisher]


Modulatory effect of Decalepis hamiltonii on ethanol-induced toxicity in transgenic Drosophila model of Parkinson's disease.
Samaneh Reiszadeh Jahromi, Mohammad Haddadi, T Shivanandappa, S R Ramesh
Neurochem Int 2014 Nov; 80C:1-6
PMID: 25451756 [PubMed - as supplied by publisher]


The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
Norbert Kovács, Zsuzsanna Aschermann, Péter Ács, Edit Bosnyák, Gabriella Deli, József Janszky, Sámuel Komoly
Ideggyogy Sz 2014 Jul; 67(7-8):245-50
PMID: 25509365 [PubMed - as supplied by publisher]


Surviving 10 years with deep brain stimulation for Parkinson's disease - a follow-up of 79 patients.
M Bang Henriksen, E L Johnsen, N Sunde, A Vase, M C Gjelstrup, K Ostergaard
Eur J Neurol 2014 Dec;
PMID: 25492023 [PubMed - as supplied by publisher]


Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.
W H Jost, M Friede, J Schnitker
Eur Rev Med Pharmacol Sci 2014 Nov; 18(22):3349
PMID: 25491607 [PubMed - as supplied by publisher]


Behavioral effects of levodopa.
Isabelle Beaulieu-Boire, Anthony E Lang
Mov Disord 2014 Dec;
PMID: 25491470 [PubMed - as supplied by publisher]


The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
Stanley Fahn
Mov Disord 2014 Dec;
PMID: 25491387 [PubMed - as supplied by publisher]


Synthesis and Pharmacological Evaluation of Dual Acting Ligands Targeting the Adenosine A2A and Dopamine D2 Receptors for the Potential Treatment of Parkinson's Disease.
Manuela Jorg, Lauren May, Frankie S Mak, Kiew Ching K Lee, Neil D Miller, Peter J Scammells, Ben Capuano
J Med Chem 2014 Dec;
PMID: 25490054 [PubMed - as supplied by publisher]


Laparoscopic-assisted percutaneous endoscopic transgastrostomy jejunostomy.
Mihail-Gabriel Dimofte, Vlad Porumb, Simona Nicolescu, Irina Ristescu, Sorinel Lunca
JSLS 2014 Oct; 18(4)
PMID: 25489214 [PubMed - as supplied by publisher]


Imaging of complications from hematopoietic stem cell transplant.
Tarun Pandey, Suresh Maximin, Puneet Bhargava
Indian J Radiol Imaging 2014 Oct; 24(4):327-38
PMID: 25489126 [PubMed - as supplied by publisher]


Clinical spectrum of levodopa-induced complications.
Camila Catherine Aquino, Susan H Fox
Mov Disord 2014 Dec;
PMID: 25488260 [PubMed - as supplied by publisher]


Levodopa: 50 years of a revolutionary drug for Parkinson disease.
Stanley Fahn, Werner Poewe
Mov Disord 2014 Dec;
PMID: 25488146 [PubMed - as supplied by publisher]


Multidisciplinary care with deep brain stimulation for Parkinson's disease patients.
Y F Cheung
Hong Kong Med J 2014 Dec; 20(6):472-3
PMID: 25488032 [PubMed - as supplied by publisher]


Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Andrew J Lees, Eduardo Tolosa, C Warren Olanow
Mov Disord 2014 Dec;
PMID: 25488030 [PubMed - as supplied by publisher]


The modulatory role of subthalamic nucleus in cognitive functions - A viewpoint.
Ivan Rektor, Martina Bo?ková, Jan Chrastina, Irena Rektorová, Marek Balá?
Clin Neurophysiol 2014 Nov;
PMID: 25487910 [PubMed - as supplied by publisher]


Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B).
Robert A Hauser, Stuart Isaacson, Jerome P Lisk, L Arthur Hewitt, Gerry Rowse
Mov Disord 2014 Dec;
PMID: 25487613 [PubMed - as supplied by publisher]


No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial.
Chizoba C Umeh, Adriana Pérez, Erika F Augustine, Rohit Dhall, Richard B Dewey, Zoltan Mari, David K Simon, Anne-Marie A Wills, Chadwick W Christine, Jay S Schneider, Oksana Suchowersky
PLoS One 2014 ; 9(12):e112287
PMID: 25486269 [PubMed - as supplied by publisher]


Behavioral phenotyping of parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
Daniel Rial, Adalberto A Castro, Nuno Machado, Pedro Garçăo, Francisco Q Gonçalves, Henrique B Silva, Angelo R Tomé, Attila Köfalvi, Olga Corti, Rita Raisman-Vozari, Rodrigo A Cunha, Rui D Prediger
PLoS One 2014 ; 9(12):e114216
PMID: 25486126 [PubMed - as supplied by publisher]


Biotherapies for Parkinson disease.
P Remy
Rev Neurol (Paris) 2014 Dec; 170(12):763-9
PMID: 25459116 [PubMed - as supplied by publisher]


A method for predicting the outcomes of combined pharmacologic and deep brain stimulation therapy for Parkinson's disease.
Reuben R Shamir, Trygve Dolbert, Angela M Noecker, Anneke M Frankemolle, Benjamin L Walter, Cameron C McIntyre
Med Image Comput Comput Assist Interv 2014 ; 17(Pt 2):188-95
PMID: 25513510 [PubMed - as supplied by publisher]


Betting on DBS: Effects of Subthalamic Nucleus Deep Brain Stimulation on Risk Taking and Decision Making in Patients With Parkinson's Disease.
Jason Brandt, Mark Rogerson, Haya Al-Joudi, Gila Reckess, Barnett Shpritz, Chizoba C Umeh, Noha Aljehani, Kelly Mills, Zoltan Mari
Neuropsychology 2014 Dec;
PMID: 25486385 [PubMed - as supplied by publisher]


Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.
Kjell Fuxe, Diego Guidolin, Luigi F Agnati, Dasiel O Borroto-Escuela
Expert Opin Ther Targets 2014 Dec; :1-22
PMID: 25486101 [PubMed - as supplied by publisher]


A method for predicting the outcomes of combined pharmacologic and deep brain stimulation therapy for Parkinson's disease.
Reuben R Shamir, Trygve Dolbert, Angela M Noecker, Anneke M Frankemolle, Benjamin L Walter, Cameron C McIntyre
Med Image Comput Comput Assist Interv 2014 ; 17(Pt 2):188-95
PMID: 25485378 [PubMed - as supplied by publisher]


Parkinson's disease: carbidopa, nausea, and dyskinesia.
Marty Hinz, Alvin Stein, Ted Cole
Clin Pharmacol 2014 ; 6:189-94
PMID: 25484598 [PubMed - as supplied by publisher]


Autophagy and ethanol neurotoxicity.
Jia Luo
Autophagy 2014 Nov; :0
PMID: 25484085 [PubMed - as supplied by publisher]


Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease.
Gennaro Pagano, Echo E Tan, Janelle M Haider, Alyssa Bautista, Michele Tagliati
Parkinsonism Relat Disord 2014 Nov;
PMID: 25483722 [PubMed - as supplied by publisher]


Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease.
Manuela Pilleri, Angelo Antonini
Expert Opin Drug Saf 2014 Dec; :1-14
PMID: 25483147 [PubMed - as supplied by publisher]


Aberrant Protein Synthesis in G2019S LRRK2 Drosophila Parkinson's Disease-Related Phenotypes.
Ian Martin, Leire Abalde-Atristain, Jungwoo Wren Kim, Ted M Dawson, Valina L Dawson
Fly (Austin) 2014 Dec; :0
PMID: 25483009 [PubMed - as supplied by publisher]


Gene therapy for Parkinson's disease: still a hot topic?
Jeffrey H Kordower
Neuropsychopharmacology 2015 Jan; 40(1):255-6
PMID: 25482182 [PubMed - as supplied by publisher]


Neuroprotective effects of a brain permeant 6-aminoquinoxaline derivative in cell culture conditions that model the loss of dopaminergic neurons in Parkinson disease.
Gael Le Douaron, Fanny Schmidt, Majid Amar, Hanane Kadar, Lucila Debortoli, Alexandra Latini, Blandine Séon-Méniel, Laurent Ferrié, Patrick Pierre Michel, David Touboul, Alain Brunelle, Rita Raisman-Vozari, Bruno Figadčre
Eur J Med Chem 2015 Jan; 89:467-79
PMID: 25462259 [PubMed - as supplied by publisher]


In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
Leonardo Pisani, Roberta Farina, Orazio Nicolotti, Domenico Gadaleta, Ramon Soto-Otero, Marco Catto, Mario Di Braccio, Estefania Mendez-Alvarez, Angelo Carotti
Eur J Med Chem 2015 Jan; 89:98-105
PMID: 25462230 [PubMed - as supplied by publisher]


Rasagiline and Pisa syndrome in Parkinson's disease patients.
Paolo Solla, Antonino Cannas, Gianni Orofino, Francesco Marrosu
Neurol Sci 2014 Dec;
PMID: 25481627 [PubMed - as supplied by publisher]


The effect of levodopa on postural stability evaluated by wearable inertial measurement units for idiopathic and vascular Parkinson's disease.
Miguel F Gago, Vitor Fernandes, Jaime Ferreira, Hélder Silva, Maria L Rodrigues, Luís Rocha, Estela Bicho, Nuno Sousa
Gait Posture 2014 Nov;
PMID: 25480163 [PubMed - as supplied by publisher]


Intrastriatal Transplantation of Adult Human Neural Crest-Derived Stem Cells Improves Functional Outcome in Parkinsonian Rats.
Janine Müller, Christiana Ossig, Johannes F W Greiner, Stefan Hauser, Mareike Fauser, Darius Widera, Christian Kaltschmidt, Alexander Storch, Barbara Kaltschmidt
Stem Cells Transl Med 2014 Dec;
PMID: 25479965 [PubMed - as supplied by publisher]


Reprint of "iPSCs, aging and age-related diseases"
Ken-Ichi Isobe, Zhao Cheng, Naomi Nishio, Thanasegan Suganya, Yuriko Tanaka, Sachiko Ito
N Biotechnol 2014 Nov; 32(1):169-179
PMID: 25479728 [PubMed - as supplied by publisher]


Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism?
Giuseppe Sancesario, Luigi Antonio Morrone, Vincenza D'Angelo, Valentina Castelli, Davide Ferrazzoli, Francesco Sica, Alessandro Martorana, Roberto Sorge, Federica Cavaliere, Giorgio Bernardi, Mauro Giorgi
Neurochem Int 2014 Dec; 79:44-56
PMID: 25452081 [PubMed - as supplied by publisher]


Novel Formulations and Modes of Delivery of Levodopa.
Werner Poewe, Angelo Antonini
Mov Disord 2014 Dec;
PMID: 25476691 [PubMed - as supplied by publisher]


Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.
T Celeste Napier, Jean-Christophe Corvol, Anthony A Grace, Jamie D Roitman, James Rowe, Valerie Voon, Antonio P Strafella
Mov Disord 2014 Dec;
PMID: 25476402 [PubMed - as supplied by publisher]


Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.
Jon Infante, Carlos Prieto, María Sierra, Pascual Sánchez-Juan, Isabel González-Aramburu, Coro Sánchez-Quintana, José Berciano, Onofre Combarros, Jesús Sainz
Neurobiol Aging 2014 Nov;
PMID: 25475535 [PubMed - as supplied by publisher]


Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease.
Navamayooran Thavanesan, Martin Gillies, Michael Farrell, Alex L Green, Tipu Aziz
Case Rep Neurol 2014 Sep; 6(3):232-7
PMID: 25473395 [PubMed - as supplied by publisher]


Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor.
Zhong-Wei Liu, Wen-Qiang Li, Jun-Kui Wang, Xian-Cang Ma, Chen Liang, Peng Liu, Zheng Chu, Yong-Hui Dang
J Zhejiang Univ Sci B 2014 Dec; 15(12):1013-22
PMID: 25471830 [PubMed - as supplied by publisher]


Noninvasive Bioluminescence Imaging of ?-Synuclein Oligomerization in Mouse Brain Using Split Firefly Luciferase Reporters.
Sarah-Ann Aelvoet, Abdelilah Ibrahimi, Francesca Macchi, Rik Gijsbers, Chris Van den Haute, Zeger Debyser, Veerle Baekelandt
J Neurosci 2014 Dec; 34(49):16518-32
PMID: 25471588 [PubMed - as supplied by publisher]


Acute and Chronic Mood and Apathy Outcomes from a Randomized Study of Unilateral STN and GPi DBS.
Michael S Okun, Samuel S Wu, Sarah Fayad, Herbert Ward, Dawn Bowers, Christian Rosado, Lauren Bowen, Charles Jacobson, Christopher Butson, Kelly D Foote
PLoS One 2014 ; 9(12):e114140
PMID: 25469706 [PubMed - as supplied by publisher]


Levodopa: the story continues].
Zh Nevrol Psikhiatr Im S S Korsakova 2014 ; 114(9):93-9
PMID: 25513357 [PubMed - as supplied by publisher]


Levodopa: the story continues].
Zh Nevrol Psikhiatr Im S S Korsakova 2014 ; 114(9):93-9
PMID: 25473661 [PubMed - as supplied by publisher]


Gait and attentional performance in freezers under methylphenidate.
A Delval, C Moreau, S Bleuse, D Guehl, E Bestaven, E Guillaud, K Dujardin, L Defebvre, D Devos
Gait Posture 2014 Oct;
PMID: 25468682 [PubMed - as supplied by publisher]


Brain-derived neurotrophic factor expression increases after enzyme replacement therapy in Gaucher disease.
Filippo Vairo, Fernanda Sperb-Ludwig, Matheus Wilke, Kristiane Michellin-Tirelli, Cristina Netto, Eurico Camargo Neto, Ida Vanessa Doederlein Schwartz
J Neuroimmunol 2014 Nov;
PMID: 25468270 [PubMed - as supplied by publisher]


Automatic behavior in Parkinson's disease.
Keiko Fusegi, Asako Yoritaka, Nobutaka Hattori, Hideo Mori
Parkinsonism Relat Disord 2014 Nov;
PMID: 25466403 [PubMed - as supplied by publisher]


Deep brain stimulation and oropharyngeal dysfunction in Parkinson's disease: A case report.
Pichet Termsarasab, Winona Tse
Parkinsonism Relat Disord 2014 Nov;
PMID: 25465743 [PubMed - as supplied by publisher]


Wide-bore 1.5T MRI-guided deep brain stimulation surgery: initial experience and technique comparison.
Karl A Sillay, Deborah Rusy, Laura Buyan-Dent, Nancy L Ninman, Karl K Vigen
Clin Neurol Neurosurg 2014 Dec; 127:79-85
PMID: 25459248 [PubMed - as supplied by publisher]


iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson's Disease.
Chris M Woodard, Brian A Campos, Sheng-Han Kuo, Melissa J Nirenberg, Michael W Nestor, Matthew Zimmer, Eugene V Mosharov, David Sulzer, Hongyan Zhou, Daniel Paull, Lorraine Clark, Eric E Schadt, Sergio Pablo Sardi, Lee Rubin, Kevin Eggan, Mathew Brock, Scott Lipnick, Mahendra Rao, Stephen Chang, Aiqun Li, Scott A Noggle
Cell Rep 2014 Nov; 9(4):1173-82
PMID: 25456120 [PubMed - as supplied by publisher]


Targeting glutamatergic synapses in Parkinson's disease.
Fabrizio Gardoni, Monica Di Luca
Curr Opin Pharmacol 2014 Nov; 20C:24-28
PMID: 25462288 [PubMed - as supplied by publisher]


Lmx1a enhances the effect of iNSCs in a PD model.
Jianyu Wu, Chao Sheng, Zhongfeng Liu, Weili Jia, Bin Wang, Mo Li, Linlin Fu, Zhenhua Ren, Jing An, Lisi Sang, Gongru Song, Yanchuan Wu, Yanling Xu, Shuyan Wang, Zhiguo Chen, Qi Zhou, Y Alex Zhang
Stem Cell Res 2014 Oct; 14(1):1-9
PMID: 25460246 [PubMed - as supplied by publisher]


Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings.
Svjetlana Miocinovic, Pravin Khemani, Rebecca Whiddon, Pam Zeilman, Daniel Martinez-Ramirez, Michael S Okun, Shilpa Chitnis
Parkinsonism Relat Disord 2014 Oct; 20(12):1434-1437
PMID: 25457819 [PubMed - as supplied by publisher]


Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies.
C Comi, L Magistrelli, G D Oggioni, M Carecchio, T Fleetwood, R Cantello, F Mancini, A Antonini
Parkinsonism Relat Disord 2014 Oct; 20(12):1329-1334
PMID: 25457816 [PubMed - as supplied by publisher]


Cancer risks among the users of ergot-derived dopamine agonists for Parkinson's disease, a nationwide population-based survey.
Vinchi Wang, Tzu-Hao Chao, Chung-Chih Hsieh, Che-Chen Lin, Chia-Hung Kao
Parkinsonism Relat Disord 2014 Oct;
PMID: 25457814 [PubMed - as supplied by publisher]


Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning.
Anne Schwerk, Jennifer Altschüler, Manfred Roch, Manfred Gossen, Christine Winter, Jürgen Berg, Andreas Kurtz, Barbara Steiner
Cytotherapy 2014 Oct;
PMID: 25457280 [PubMed - as supplied by publisher]


Viewpoint: Challenges in our understanding of neuroleptic induced parkinsonism.
Joseph H Friedman
Parkinsonism Relat Disord 2014 Oct; 20(12):1325-1328
PMID: 25456826 [PubMed - as supplied by publisher]


Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome.
Lucia Ricciardi, Carla Piano, Anna Rita Bentivoglio, Alfonso Fasano
Parkinsonism Relat Disord 2014 Oct; 20(12):1445-1446
PMID: 25455696 [PubMed - as supplied by publisher]


Dyskinesias and motor symptoms onset in Parkinson disease.
Anna Latorre, Maria Carmela Bloise, Carlo Colosimo, Francesca Di Biasio, Giovanni Defazio, Alfredo Berardelli, Giovanni Fabbrini
Parkinsonism Relat Disord 2014 Oct; 20(12):1427-1429
PMID: 25455693 [PubMed - as supplied by publisher]


Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study.
Yoshikuni Mizuno, Masahiro Nomoto, Kazuko Hasegawa, Nobutaka Hattori, Tomoyoshi Kondo, Miho Murata, Masahiro Takeuchi, Masayoshi Takahashi, Takayuki Tomida,
Parkinsonism Relat Disord 2014 Oct; 20(12):1388-1393
PMID: 25455692 [PubMed - as supplied by publisher]


A novel treatment target for Parkinson's disease.
Chandramohan Wakade, Raymond Chong
J Neurol Sci 2014 Oct; 347(1-2):34-38
PMID: 25455298 [PubMed - as supplied by publisher]


Can dopamine agonists trigger tactile hallucinations in patients with Parkinson's disease?
Hiroshi Kataoka, Nobuhiro Sawa, Kazuma Sugie, Satoshi Ueno
J Neurol Sci 2014 Oct; 347(1-2):361-363
PMID: 25454646 [PubMed - as supplied by publisher]


Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Nicolaas I Bohnen, Vikas Kotagal, Martijn L T M Müller, Robert A Koeppe, Peter J H Scott, Roger L Albin, Kirk A Frey, Myria Petrou
Parkinsonism Relat Disord 2014 Oct; 20(12):1394-1398
PMID: 25454317 [PubMed - as supplied by publisher]


Clinical and electrophysiological features in a French family presenting with seipinopathy.
Yolaine Ollivier, Armelle Magot, Philippe Latour, Julie Perrier, Sandra Mercier, Thierry Maisonobe, Yann Péréon
Neuromuscul Disord 2014 Oct;
PMID: 25454168 [PubMed - as supplied by publisher]


Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms.
Marilena Aiello, Roberto Eleopra, Raffella I Rumiati
Appetite 2014 Oct; 84C:204-211
PMID: 25453591 [PubMed - as supplied by publisher]


Impulsive and compulsive behaviors in Parkinson's disease.
Guoxin Zhang, Zhentao Zhang, Ling Liu, Jiaolong Yang, Jinsha Huang, Nian Xiong, Tao Wang
Front Aging Neurosci 2014 ; 6:318
PMID: 25452726 [PubMed - as supplied by publisher]


Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients.
Jean-Marc Melgari, Giuseppe Curcio, Francesca Mastrolilli, Gaetano Salomone, Laura Trotta, Mario Tombini, Lazzaro di Biase, Federica Scrascia, Rita Fini, Emma Fabrizio, Paolo Maria Rossini, Fabrizio Vernieri
Front Aging Neurosci 2014 ; 6:302
PMID: 25452725 [PubMed - as supplied by publisher]


The causative gene of parkinsonism and its medical treatment strategy.
Masatoshi Inden
Yakugaku Zasshi 2014 ; 134(12):1253-8
PMID: 25452235 [PubMed - as supplied by publisher]


Presynaptic Effects of Levodopa and Their Possible Role in Dyskinesia.
Eugene V Mosharov, Anders Borgkvist, David Sulzer
Mov Disord 2014 Dec;
PMID: 25450307 [PubMed - as supplied by publisher]